Yale Urology, named one of the nation’s best urology programs by U.S. News & World Report, is committed to provide advanced care, train future leaders, and discover novel approaches to urologic conditions. Visit us at medicine.yale.edu/urology. Follow us on Twitter/X @Yale_Urology, Linkedin [Yale School of Medicine Department of Urology], and/or YouTube @yaleurologyOfficial to view Grand Rounds and other special event videos.
Yale professors create new drug that could combat prostate cancer
October 12th 2022A Yale chemist and oncologist collaborated to create a new treatment for prostate cancer that tags specific proteins within the cancerous cells, making it easier for the body’s natural mechanisms to identify and destroy them.
Yale urology chair reflects on first year
September 27th 2022"I have no doubt we’ll become a destination program. We have a great team. Combined with a few key recruitments, we will be set to take our place on the global stage of urology," says Isaac Y. Kim, MD, PhD, MBA, urology professor and chair, Yale Urology.
For Medicaid-insured patients with cancer, health insurance does not always mean health access
July 19th 2022“We found that Medicaid acceptance differed widely across cancer care facilities," said Michael Leapman, MD, MHS, associate professor of Urology, clinical program leader for the Prostate & Urologic Cancers Program at Yale Cancer Center and Smilow Cancer Hospital.
Dr. Petrylak highlights the latest advances in metastatic urothelial cancer
March 22nd 2022In discussing treatment determinations, Petrylak noted that for patients with low PD-L1 expression had decreased survival benefits compared with patients treated with chemotherapy in the monotherapy arms of the phase 3 KEYNOTE-361 (NCT02853305) and phase 3 IMVIGOR-130 (NCT02807636) trials.
PAE safe, durable for retention, hematuria in non-index BPH patients
January 28th 2020Prostatic artery embolization offers a safe and durably effective treatment for urinary retention and gross hematuria in challenging non-index BPH patients, according to the results of a retrospective study published in Urology (Nov. 14, 2019 [Epub ahead of print]).
Emergent setting linked to lost follow-up for stents
May 8th 2019Patients with ureteral stents are rarely lost to follow-up, but the risk is increased when patients are stented in an emergent setting rather than as part of an elective procedure, Yale University urologists reported at the 2018 World Congress of Endourology in Paris.